HIGHLIGHTS
- who: Pedro Mateu-Gelabert from the National Statistical Institute of University of California, Los Angeles, United States have published the research: Hepatitis C virus risk among young people who inject drugs, in the Journal: (JOURNAL)
- what: The study was approved by NDRI's Institutional Review Board, and all participants provided written informed consent. This study reports an overall HCV antibody prevalence of 30.4% for a community sample of young people ages 18-29 who injected drugs, recruited between 2014-2016 in NYC. It is worth noting that the overall prevalence the authors report here . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.